{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:58:22Z","timestamp":1791910702176,"version":"4.3.4"},"reference-count":7,"publisher":"Societas Neurologica Japonica","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2012]]},"DOI":"10.5692\/clinicalneurol.52.1047","type":"journal-article","created":{"date-parts":[[2012,11,28]],"date-time":"2012-11-28T22:58:02Z","timestamp":1354143482000},"page":"1047-1050","source":"Crossref","is-referenced-by-count":1,"title":["Directions for use of corticosteroids and calcineurin inhibitors against generalized myasthenia gravis: therapeutic strategies that can lead to early improvements and veer away from high-dose oral corticosteroids"],"prefix":"10.5692","volume":"52","author":[{"given":"Kimiaki","family":"Utsugisawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Nagane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"2) Sanders DB, Evoli A. Immunosuppressive therapies in myasthenia gravis. Autoimmunity 2010;43:428-435.","DOI":"10.3109\/08916930903518107"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3) Grob D, Brunner N, Namba T, et al. Lifetime course of myasthenia gravis. Muscle Nerve 2008;37:141-149.","DOI":"10.1002\/mus.20950"},{"key":"3","doi-asserted-by":"crossref","unstructured":"5) Schneider-Gold C, Gajdos P, Toyka KV, et al. Corticosteroids for myasthenia gravis. Cochrane Database Syst Rev 2005;CD002828.","DOI":"10.1002\/14651858.CD002828.pub2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"6) Masuda M, Utsugisawa K, Suzuki S, et al. The MG-QOL15 Japanese version: validation and associations with clinical factors. Muscle Nerve 2012 in press.","DOI":"10.1002\/mus.23398"},{"key":"5","doi-asserted-by":"crossref","unstructured":"7) Suzuki Y, Utsugisawa K, Suzuki S, et al. Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study. BMJ Open 2011;1:e000313.","DOI":"10.1136\/bmjopen-2011-000313"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1159\/000322497"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2008.02130.x"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u5168\u8eab\u578bMG\u6cbb\u7642\u306e\u5230\u9054\u76ee\u6a19\u3068\u526f\u814e\u76ae\u8cea\u30b9\u30c6\u30ed\u30a4\u30c9\uff0c\u30ab\u30eb\u30b7\u30cb\u30e5\u30fc\u30ea\u30f3\u30a4\u30f3\u30d2\u30d3\u30bf\u30fc\u306e\u4f7f\u7528\u6cd5"],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T20:03:43Z","timestamp":1621541023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/clinicalneurol\/52\/11\/52_1047\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":7,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.52.1047","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}